Vertex Pharmaceuticals Aktie
WKN: 882807 / ISIN: US92532F1003
|
03.08.2026 22:23:14
|
Vertex Pharmaceuticals Inc. Profit Climbs In Q2
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) announced earnings for its second quarter that Increases, from the same period last year
The company's earnings came in at $1.099 billion, or $4.31 per share. This compares with $1.032 billion, or $3.99 per share, last year.
Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.207 billion or $4.73 per share for the period.
The company's revenue for the period rose 12.4% to $3.333 billion from $2.964 billion last year.
Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings: $1.099 Bln. vs. $1.032 Bln. last year. -EPS: $4.31 vs. $3.99 last year. -Revenue: $3.333 Bln vs. $2.964 Bln last year.
-Guidance: Full year revenue guidance: $ 13.1 B To $ 13.2 B
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vertex Pharmaceuticals Inc.
Analysen zu Vertex Pharmaceuticals Inc.
Aktien in diesem Artikel
| Vertex Pharmaceuticals Inc. | 414,25 | 1,52% |
|